Company Profile
Updated: 28-OCT-09Silence Therapeutics AG
Non-Quoted Public Company
Robert-Roessle-Str 10, Berlin, D-13125, Germany
()49 030 94 89 28 00, 49 030 94 89 28 01 fax, http://www.silence-therapeutics.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Biopharmaceutical company with core competence in functional gene silencing. atugen pursues a dual business strategy comprising in-house drug development programs and a contract research business with high-profile pharmaceutical companies
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
'One-Stop Shop' RNAi Delivery Firm; Silence, Intradigm Merge.
BIOWORLD Today; 12/17/2009; 1112 words; ...Managing Editor UK-listed Silence Therapeutics plc and privately held...Pharmaceuticals Inc. and Sirna Therapeutics Inc. The RNAi space...likes of Roche Holdings AG and Novartis AG, and...deliver RNAi-based therapeutics to disease targets...
Opko Hopes To Mop Up With Trial On Wet AMD.
BIOWORLD Today; 11/3/2009; 1258 words; ...QLT Inc. and Novartis AG, managed $61.2 million...Quark Biotech Inc. and Silence Therapeutics plc. Another company...partner Bayer Healthcare AG using its VEGF trap approach...who can forget Sirna Therapeutics Inc.'s $1.1 billion...
NewCo News: Tacere Tries A New Strategy By Fighting HCV With RNAi.
BIOWORLD Today; 11/3/2009; 1132 words; ...the Italian word for silence. As of now, they are...deal with Roche Holding AG, and Silence Therapeutics plc inked a potential...RNAi-leader Sirna Therapeutics Inc. for $1.1 billion...Laboratories Inc. Novartis AG has been particularly...
Alnylam Captures Potential $1B Roche Licensing Deal.
BIOWORLD Today; 11/3/2009; 1194 words; ...billion from Roche Holding AG - with $331 million...keep working on RNAi therapeutics discovery. Work there...week, the RNAi firm Silence Therapeutics plc, of London, partnered...rival RNAi firm, Sirna Therapeutics Inc., of San Francisco...
Alnylam Gets $38.6 Million Grant For RNAi Antivirals.
BIOWORLD Today; 11/3/2009; 1369 words; ...RNAi include Tacere Therapeutics Inc., which encapsulates...layered nanoparticle; and Silence Therapeutics plc, which chemically...systemically delivered RNAi therapeutics within its internal...deal with Roche Holding AG. (See BioWorld Today...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning